~~~[~iirlll!t~tll (~/ ' / ' / 1 ( 1 r t~7~i~~o I o~y j~, Diikc Lrtiivor.\i/!, .\lc,dii~11 C'cti~cr, Di/r/i(~tl~, ~\'or~/i C7(iroliti (i 27710 ABSTRACT. Glucocorticoids promote lung cell differen-for surfactant synthesis. This beneficial effect has led to widetiation and thus enhance surfactant synthesis in the man-spread use of glucocorticoids by obstetricians and pediatricians agement of neonatal respiratory distress syndrome. Be-to prevent or treat neonatal respiratory distress syndrome in cause they also accelerate differentiation in other targets, infants born prematurely. However, enhanced cell difTcrentiation glucocorticoids may compromise physiologic responses comes at the expense of cell proliferation (1). leading to shortfalls that operate through specialized fetal-neonatal mecha-in lung cell number, especially at the high doses typical of clinical nisms. The current study csplores one such process, the steroid use (2). The compound effects of glucocorticoid exposure capacity to maintain cardiac function during hyposia, a during development, sacrificing cell division in favor of differcritical function in light of the hyposia associated with entiation. are also seen in systems other than the intended parturition and with neonatal respiratory distress. Preg-therapeutic target: in the nervous system, general impairment of nant rats were given 0.05, 0.2, or 0.8 mg/kg of desameth-cell acquisition is paired with selective promotion of developasone on gestational d 17, 18, and 19, and the response to ment of a number of neurotransmitter systems, most notably hyposia was assessed in the offspring on the day after catecholaminergic pathways (3-6). In the liver, targeting of catebirth. Desamethasonc produced a dose-dependent impair-cholamine ncurotr~nsmission leads to a premature transition ment of survival during esposure to 5% 01 (5 kPa 0 2 ) for from fetal ij-receptor-mediated control of glucose metabolism to 120 min. ECG measurements showed that death in the the adult mechanism dominated by tul-receptors (7). Unlike the desamethasone-exposed animals was preceded by multiple situation in the lung. where an accelerated time course of cell arrhythmias and progressive atrioventricular conduction differentiation is beneficial in treating respiratory distress syndefects, terminating in cardiac arrest. Because maintenance drome, the promotional effect on hepatic adrcnergic mechanisms of neonatal cardiac conduction during hyposia depends on is detrimental. ij-Adrenergic dominance in the fetal-neonatal adrenergic mechanisms operating through adrenomedul-period is adaptive for the carbohydrate-poor milk diet that relary catecholamine release and actions at transiently cs-quires gluconeogenesis: this metabolic process is effectively pressed a*-receptors in the immature myocardium, we linked to @-receptors, with the appropriate stimulus supplied by examined these mechanisms in control and desametha-a ij-adrcnergic agonist (epinephrine) released from the adrenal sone-esposed neonates. Desamethasone caused cardiac a*-medulla in the absence of functional sympathetic innervation: receptors to disappear prematurely, an effect that was glucose metabolism in adults, on the other hand, is controlled selective for this receptor population because no compa-by cu-receptors stimulated by norepinephrine release from symrable changes were seen in a,-receptors. Under normal pathetic neurons, producing glycogenolysis appropriate to the circumstances, neonatal adrenomedullary responses to hy-mature, carbohydrate-rich diet (8-12). posia operate in the absence of functional sympathoadrenal In general. then. it would be predicted that promotion of cell innervation, and cardiac-sympathetic innervation does not differentiation by glucocorticoid exposure will enhance physioplay a significant role; in a similar fashion, the desameth-logic function of systems that arc inadequately developed in the asone-esposed animals did not display alterations in the fetus or neonate but will have deleterious effects on function functional state of sympathetic innervation of the adrenal when immature cells express a mechanism that is specialized to medulla or heart at birth. Nevertheless, adrenomedullary a specific maturational stage. Such a situation may exist in the catecholamine levels and the secretory response to hyposia developing heart, where both muscle structure and adrenergic were significantly impaired by prenatal desametl~asone function have properties that are uniquely different from those exposure, probably a s a result of adrenal atrophy caused of the adult. First, the type of myosin heavy chain molecule by the glucocorticoid. These results indicate that esposure found in the fetal rat heart is the &form. characterized by low to glucocorticoids in doses commensurate with their ther-ATPase activity and a slow rate of shortening. attributes that are apeutic actions on lung function evokes premature loss of advantageous in the relatively 02-poor environment of fetal life the unique fetal-neonatal adrenergic mechanisms that are and parturition (13-15). Expression of tu-myosin heavy chain. required to preserve cardiac function during hyposia. (Pe-with high ATPase activity and a rapid rate of shortening, indiatr
Weight results were combined for both males and females because there was no interaction of sex and treatment: values wcre compiled from no more than two pups from each litter (one male and one female). Dex, dexamethasone; ANOVA, analysis of variance.
t Significantly different from corresponding control value.
either prewarmed, humidified room air or 7 kPa 0 2 plus 93 kPa
Nz for a total of 90 min. At the end of this period, animals were decapitated, the left adrenal glands were dissected immediately, and the tissues were homogenized in 1 m L of ice-cold 0.1 N HClOd containing 300 ng of 3,4-dihydroxybenzylamine (Sigma) as a n internal standard. Similarly, adrenal catecholamine release in response to hypoglycemia, which occurs by reflex activation of the splanchnic nerve (30) , was tested by giving 20 IU/kg of insulin S.C. (Eli Lilly 61 Co., Indianapolis, IN) or an equivalent volume of isotonic saline; 3 h later, pups were killed and the adrenal glands prepared for analysis as already described. When adrenal innervation is functional, this test produces release of
30-60% of the total content of catecholamines (3 I, 32).
Adrenal homogenates wcre scdimented at 26 000 x g for 10 min, and supernatant solutions were stored at -20°C. Catecholamines were first isolated by alumina adsorption, resuspended in 250 pL of 0.2 N perchloric acid, and then analyzed by HPLC with electrochemical detection (33) . All values were corrected for recovery of the internal standard.
Cardiac rlorc~pinc~pllrirlc rclcasc. T o assess whether dcxamethasone alters the functional development of the cardiac-sympathetic axis, we assessed the reflex release of norepinephrine from cardiac sympathetic nerves with 2-deoxyglucose challenge (33) . Pups were weighed and given 0-methyl-p-tyrosine methyl ester (300 mg/kg intraperitoneally; Sigma) to prevent norcpinephrine resynthesis: this procedure is necessary when measuring cardiac norepinephrine release, but not adrenal catecholamine release. because of the greater rapidity of neuronal catecholamine biosynthesis (33, 34) . Fifteen minutes after tr-methyl-p-tyrosine methyl ester administration, pups were injected with 2-deoxyglucose (2 g/kg intraperitoneally), which causes cellular glycopenia and thus evokes centrally mediated stimulation of cardiac sympathetic neurons (33), or with an equivalent volume of saline (3 mL/kg). Animals were decapitated 2.5 h later, and heart norepinephrine was determined as described for adrenal catecholamine analysis. Because of the low levels of norcpinephrine present in neonatal rat heart, three to four hearts were pooled for each sample. When cardiac sympathetic innervation is functional, this challenge produces release of 25-50% of neuronal norepinephrine stores (33) .
Da!a atzalj~sis. Data are presented as means f SEM. Statistical comparisons of the effects of dexamethasone on static measures were canied out with one-factor analysis of variance (control I'ETSI~S dexamethasone) with post hoc evaluation of each dexamethasone dosage group to the control using Dunnett's I test. For studies involving short-term interventions of hypoxia or hypoglycemia, comparisons wcrc carried out by two-way analysis of variance, considering factors of prenatal treatment (control verslrs dexamethasone) and the short-term test (room air verslrs low 02: saline rrr.ur.7 insulin). Although some results are presented as percentages of control values, statistical tests wcrc conducted only on the raw data. Nonparametric variables (incidence of death, proportion of pups showing arrhythmias during hypoxia, proportion of dams giving birth), were evaluated by Fisher's exact test. Scatchard plots of receptor binding wcre fitted by linear regression analysis. For all tests. significance was assumed at p < 0.05.
RESULTS
In accordance with previous studies. dexamethasone administration resulted in a dose-dependent retardation of maternal weight gain and a higher incidence of neonatal dcath in the group exposed to the highest dose (Table I) . However, neither litter size nor the proportion of dams giving birth wcre affected; no difference in sex ratios was observed (data not shown). Neonatal body weights and heart weights were decreased by dexamethasone, but heart weight was spared relative to body weight. producing a relative cardiomegaly in the 0.8 mg/kg group. Again. these effects have been noted previously (35. 36 The typical ECG in control pups showed a n early decrease in heart rate and lengthening of atrioventricular conduction time (increased PR interval) beginning at the onset of hypoxia and followed by stabilization at the lower rate and lengthened conduction time from about 30 min onward (Fig. I) . In general, normal sinus rhythm was maintained in the control pups, and the only notable change in ECG wave form was an elevation in the T wave. Even in the few cases where control pups died during hypoxia. these animals exhibited normal ECG results immediately before the cessation of breathing. implicating respiratory arrest as the immediate cause of death.
Unlike the situation in control pups. ECG evaluations in the dexamethasone group indicated that the high rate ofdeath during hypoxia was attributable to cardiac arrest ( Fig. I) : in every case, dcath was preceded by arrhythmias. characterized by progressive atrioventricular conduction defects and grossly exaggerated T waves. Arrhythmic episodes in the group receiving the highest dose of dexamethasone occurred three to four times more frequently than in controls (Fig. 2) . Control animals never exhibited more than one episode of arrhythmias during the hypoxic test period, whereas the dcxamethasone-exposed animals often showed multiple episodes: in virtually every case, the animals showing multiple arrhythmias died after the second incidence of atrioventricular block.
Prenatal exposure to dcxamethasone elicited differences in cardiac function during hypoxia even for animals in the treated group that did not die. First, the dexamethasone pups began with a significantly lower resting heart rate and an already prolonged
Control
Heart Rate 377 bpm In the adult, cardiac slowing, lengthened atrioventricular conduction time, and arrhythmias are often a consequence of activation of the vagal parasympathetic innervation and can thus be prevented with a muscarinic blocking agent, such as atropine. Accordingly, we tested whether atropine would influence heart rate responses to hypoxia in control or dexamcthasonc-treated pups. Atropine failed to evoke a significant increase in resting hcart rate in either group, indicating little or no tonic vagal control of heart rate ( Fig. 4) . Effects of atropine on heart rate during hypoxia were tested at the 30-min exposure time, the point of maximum slowing in controls and of maximal separation of heart rate changes between the control and dexamethasone cohorts. Atropine did not prevent cardiac slowing in the controls, and the obtunded response was still apparent in the dexamcthasone group.
We next concentrated on potential adrcncrgic mechanisms Fig. 1 . Sample ECG recordings from control animals and animals that could participate in the deleterious effects of dexamethasone exposed prenatally to 0.8 rng/kg of dcxamcthasone. ..I. Baseline readings on cardiac function during hypoxia. Because n2-adrencrgic rccepshow a slower heart rate in the dexamethasone group and a prolonged tors are transiently overexpressed in developing heart (18) and PR interval but maintenance of normal sinus rhythm and ECG wave are essential to maintaining conduction characteristics during form. B, After 13 rnin of 5 kPa 0 2 balanced with Nz. the control animal hypoxia (20), we evaluated the effects of dexamcthasone on shows a slowing of heart rate, a lengthening of the PR interval, and slight expression of these receptors (Fig. 5) . Measurement of [3H] enhancement of the T wave, the dcxamcthasone animal has gone into rauwolscine binding to cardiac membrane preparations showed 2nd degree atrioventricular ('1-L3 block, with two P waves required to significant decrements of 25-30% at all doses of dexamcthasonc elicit one QRS complex, and a grossly exaggerated T wave. C, Immedi-even when corrected for nonspecific growth inhibition by norately thereafter (I4 rnin), the heart rate in the dexamethasone animal has malizing the values of membrane protein concentrations. Scatbecome extremely variable, and the PR interval changes from beat to chard analysis conducted on membrane preparations from anibeat; 2nd-degree block is still occasionally seen. D, In another pair of mals in the control and 0.8 mg/kg dexamethasone groups (Fig.  animals, by 30 rnin the control animal has again slowed its hcart rate 6) confirmed that the alterations in n2-receptor binding reflected and lengthened its PR interval but has maintained a normal wave form; changes in the number of receptors (maximum binding capacity), the dexamethasone animal has maintained the ratc and interval at its not receptor binding afinity (equilibrium constant). The selecnormoxic values but shows an exaggerated T wave. E, At 56 rnin in this tivity toward n2-receptors was confirmed by parallel asscssmcnt pair of animals, the control still has a normal ECG wave form with the of ['H]prazosin binding to n,-rcccptors, which are not transiently reduced heart rate and lengthened PR interval. whereas the dcxamctha-overexpressed during development. In contrast to the dcxamethsone animal has gone into 2nd-degree atrioventricular block.
asone-induced decreases seen in cu2-receptor binding, nl-receptors were not significantly affected overall and showed only slight PR interval even under normoxic conditions (Table 2) . With the decrements (10-12%, NS) even when the dose of dcxamcthasone commencement of hypoxia, as noted above, control animals was raised to growth-inhibiting levels (Fig. 5) . produced a progressive lowering of heart rate that stabilized by Adrenergic effects on a?-receptors regulating cardiac perform-30 min; however, the dexamethasone group reduced their heart ance during neonatal hypoxia require release of adrenal caterates much more slowly (Fig. 3) . Similarly, whereas controls cholamines because cardiac sympathetic innervation is nonfunc-DEXAMETI1ASONE-HYPOXIA INTERACTIONS 519 reflex metabolic stressor (33). As expected, 2-deoxyglucose produced no norepinephrine release from sympathetic nerves in 1- Fig. 3 . Change in hcart ratc caused by breathing 5 LPa 0: in control d-old control rats: saline, 4 1 f 2 ng/g heart (1 5 animals); 2-animals and animals exposed to 0. 8 tional at birth (12) . Accordingly, we examined adrenal catecholamine levels and secretion of catecholamines during hypoxia. The total adrenal catecholamine content of the neonatal adrenal gland was significantly decreased by dexamethasone exposure ( p < 0.0001), with a selective, dose-dependent deficit in the content of epinephrine without comparable effects on norepinephrine (Fig. 7) . There was a parallel effect of dexamethasone on adrenal catecholamine secretion in response to hypoxia (Fig. 8) . Epinephrine secretion in control animals exposed to 7 kPa 0 2 for 90 min amounted to 70 ng/gland, approximately 20% of the entire content of the adrenal gland. Adrenomedullary secretion triggered by hypoxia was reduced by half in the animals exposed to the highest dose of dexamethasone.
The direct neonatal adrenal secretory response to hypoxia occurs without participation of splanchnic innervation, which does not become functional until the end of the 1st postnatal week (30). Accordingly, it was important to test whether the adverse effects of dexamethasone on adrenal responsiveness reflected alterations in the development of sympathoadrenal innervation, namely, premature innervation and loss of the auton-
DISCUSSION
Results obtained in this study indicate that prenatal dexamethasone treatment adversely affects the neonate's ability to withstand hypoxia of the magnitude experienced during parturition (23. 24) . A dose-dependent increase in mortality was seen during hypoxic challenge, with statistically significant effects obtained in both of the groups receiving doses of dexamethasone within the range for therapeutic use in treating respiratory distress (0.2 and 0.8 mg/kg) (2 1, 22). Our examination of the mechanisms underlying the loss of hypoxia tolerance indicates that no single effect of dexamethasone is responsible but rather that actions on multiple systems converge on cardiac function as the critical element.
The neonate's ability to withstand hypoxia involves unique. transiently expressed cellular events that are carefully coordinated to maintain cardiac rhythm in the face of a restricted energy supply. First, hypoxia causes secretion of catecholamines from the adrenal medulla into the circulation. a process that occurs despite the absence of functional neuronal connections between the CNS and the adrenal gland (19) ; indeed, with the 
-125
1 m,~ a x . ws.
I -1 50 Control
Dex 0. 8 
Prenatal Treatment
Prenatal Treatment Fig. 4 . Effects of atropine pretrcatmcnt on rcsting hcart rate (Il:/i prrtri81) and on the heart rate response to hypoxia (5 LPa 0: for 30 min: ri,clrl puncl) in control animals and animals exposed to 0.8 mg/Lg of dcxamcthasonc (Ili..~) prenatally. Data represent means + SEM obtained from six to 18 animals in each group at each agc. The main effect of dexan~ethasonc alone was statistically significant with regard to both resting heart ratc and the response to hypoxia. Atropine itself had no significant cfl>ct on cither resting heart ratc or on the response to hypoxia, nor did it reverse thc lowcring of rcsting hcart rate or hcart ratc responses in the dcxanicthasonc group (no significant interaction of dcxamcthasonc and atropine). onset of functional innervation, this unique ability is lost. The catecholamines then act on transiently expressed myocardial nzadrenergic receptors, a receptor population that is prominent in the fetus and neonate but not in the adult (18); these receptors affect cardiac pacemaker and conduction characteristics so as to maintain a normal sinus rhythm during hypoxia (20, 37) , actions that are aided by the presence of the 8-myosin heavy chain (16) , a slow contractile protein that rcquircs relatively less ATP than does the mature n-form (1 3-1 5). It is thus the combined circumstance of nonncurogenic adrenomedullary responses, transiently expressed cardiac adrenergic receptors, and a fetal, encrgy-conservative myosin phenotype that renders the immature heart resistant to hypoxia of the magnitude that is experienced during parturition. Our results show that all of these processes are compromised by prenatal glucocorticoid administration. In control animals, the specialized adrenomedullary and cardiac mechanisms produced a slowing of heart rate and a lengthening of atrioventricular conduction time (increased PR interval) during hypoxia, mcasurcs that arc conservative of cardiac work and energy use; nearly all of the controls thus maintained a relatively normal ECG wave form and sinus rhythm throughout the hypoxic period. In contrast, prenatal dexamcthasone treatment led to loss of nearly 30% of the animals, with death attributable to cardiac arrhythmias and subsequent cardiac arrest. Even in the resting, normoxic state, dexamethasone-treated animals showed depressed heart rate and slowed atrioventricular conduction (lengthened PR interval); but unlike the controls, the dexamethasone-exposed animals took much longer to reduce DEXAMETHASONE-HYPOXIA INTERACTIONS 52 1 their heart rate in response to hypoxia and showed no further lengthening of the PR interval until they actually proceeded into frank arrhythmias or complete 2nd-degree atrioventricular block. None of these changes reflected alterations in parasympathetic function, as established by the inability of atropine to alter either the differences in the resting state or during hypoxia.
The particular set of hypoxia-induced ECG abnormalities in the dexamethasone group is identical with that seen when adrenergic mechanisms are obstructed in control rats during hypoxia (20) . Accordingly, we next examined whether dexamethasone influences the unique adrenergic components of the hypoxia response in neonates. Indeed, the n2-adrcnergic receptors that are uniquely overexpressed in the fetal-neonatal heart were significantly reduced even at the lowest dose of dexamethasone. This effect was selective in that n o such actions occurred with n,:receptors, which are not overexpressed; previous work has also established that @-receptors are unaffected by this treatment (38, 39) . a2-Receptor binding was reduced to a level that would ordinarily be found in animals I wk older (18), a n age at which the specialized neonatal ability of the myocardium to maintain rhythm during hypoxia has been lost (20) .
Although dexamcthasone-induced alterations in cardiac receptor development participate in the loss of hypoxia tolerance, it is apparent that effects on receptors alone cannot account for the loss of adaptation; effects on rcccptors were already maximal at the lowest dexamethasone dose, whereas hypoxia-induced mortalitv showed a distinct increase with dose. Conseauentlv. studies of adrenomedullary function wcre undertaken th'at shoGed that dexamethasone also interfered with catccholaminc output in response to hypoxia, with a statistically significant effect seen at the highest dose of dexamethasone. The actions on catecholamine secretion in response to hypoxia were reflected in changes in basal adrenal catecholamine levels in the normoxic state, suggesting deleterious effects of dexamethasone on adrcnomedullary development rather than interference with a spccific secretory component. Because of the unique circulatory organization of the adrenal gland, with the venous cflluent of the cortex providing the arterial supply of the medulla, the development and function of the catecholamine-containing cells of the adrenal medulla are closely intertwined with that of the adrenal cortex. High levels of adrenal corticosteroids provide the signal for the development of adrenomedullary phcnylethanolamine-hr-mcthyltransferase (40), the enzyme required for the synthesis of epinephrine from norepinephrine. Previous work has shown that, in animals treated with exogenous corticosteroids, feedback inhibition of the hypothalamus-pituitary-adrenal axis causes adrenocortical atrophy and attendant interference with adrenomedullary development (41, 42) . In the current study, we found a spccific, dose-dependent decrease in epinephrine in the adrenal glands of dexamethasonc-treated neonates, commensurate with suppression of adrenocortical function. An attractive alternative hypothesis is that dexamethasone instead alters the timing of the onset of functional innervation of the adrenal medulla, a possibility suggested by findings that glucocorticoids can enhance cholinergic synaptogenesis in peripheral target tissues (43): however, this hypothesis was ruled out by the absence of a response to insulin, which evokes reflex activation of the splanchnic nerve to produce catecholamine secretion (30) in either the control or dexamethasone group. Similarly, alterations in the functional development of cardiac sympathetic nerves wcre ruled out with testing of reflex activation by 2-deoxyglucose.
Accordingly, the insufficiency of adrenergic responsiveness in dexamethasone-exposed neonates, and their consequent inability to survive hypoxia, is a combined defect of inadequate adrenal catecholamine o u t~u t and i m~a i r m e n t of the swecializcd. n7-adrenergic receptor population in the myocardium. Because glucocorticoids also accelerate cardiac cell differentiation, leading to premature replacement of the energy-conservative &myosin heavy chain with tu-myosin (l7), which has higher ATPase activity, these effects are superimposed on increased energy demand, compromising the neonate's ability to maintain cardiac function. Interference with the ability to survive hypoxia is particularly important in light of the current practice of administering corticosteroids to enhance lung function in preterm babies because these infants are likely to experience hypoxia as a result of respiratory immaturity. These results also raise questions about prenatal risk factors that evoke secretion of endogenous corticosteroids, including maternal stress or exposure to environmental toxicants. On the basis of our findings, we would predict that any factor producing a prolonged elevation of glucocorticoids in the maternal-fetal unit will lead to increased mortality during hypoxic episodes, including those associated with parturition. respiratory distress, or sleep apnea as a prelude to sudden infant death syndrome.
